Literature DB >> 11832492

Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.

Peter Pediaditakis1, Satdarshan P S Monga, Wendy M Mars, George K Michalopoulos.   

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine that is involved in many normal as well as pathological conditions. HGF/NK1, a splice variant of HGF/SF, has been reported to have either antagonistic or agonistic effects with regard to c-Met signaling depending on the cell type. In these experiments, we have determined that HGF/NK1 is a potent mitogen for rat hepatocytes in culture. Furthermore, we have found that coagulation factor Xa (fXa) is capable of cleaving HGF/NK1 and single chain HGF/SF (scHGF/SF). The products resulting from cleavage of HGF/NK1 or scHGF/SF by fXa appear as single bands under non-reducing conditions. The reaction products from the digestion of HGF/NK1 by fXa were separated under reducing conditions, and the cleavage site, as determined by N-terminal sequencing, was located C-terminal to arginine 134. Previous work established that the heparin-binding domain for HGF/SF is located in the N domain of HGF/SF. Additionally, the dimerization of the HGF/SF receptor (c-Met) by the ligand HGF/NK1 is facilitated by heparin and related sulfonated sugars on the cell surface, whereas heparin is not required for HGF/SF-mediated dimerization. Cleavage of single chain HGF/SF or HGF/NK1 by factor Xa does not alter the affinity of the respective molecules for heparin, but it did variably affect the associated mitogenic activity of these factors. The associated mitogenic activity of HGF/NK1 was reduced by more than 90%, whereas the mitogenic activity of scHGF/SF was unaffected. This suggests mandatory maintenance of a steric interaction of the N domain and the first kringle domain for HGF/NK1 to act as an agonist for rat hepatocyte growth but is not required by full-length HGF/SF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832492      PMCID: PMC1821081          DOI: 10.1074/jbc.M112196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.

Authors:  D Y Chirgadze; J P Hepple; H Zhou; R A Byrd; T L Blundell; E Gherardi
Journal:  Nat Struct Biol       Date:  1999-01

2.  Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

Authors:  S J Stahl; P T Wingfield; J D Kaufman; L K Pannell; V Cioce; H Sakata; W G Taylor; J S Rubin; D P Bottaro
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

3.  Identification of heparin-binding stretches of a naturally occurring deleted variant of hepatocyte growth factor (dHGF).

Authors:  M Kinosaki; K Yamaguchi; A Murakami; M Ueda; T Morinaga; K Higashio
Journal:  Biochim Biophys Acta       Date:  1998-04-23

4.  NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.

Authors:  J L Jakubczak; W J LaRochelle; G Merlino
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

Authors:  S Mizuno; T Kurosawa; K Matsumoto; Y Mizuno-Horikawa; M Okamoto; T Nakamura
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 6.  The hepatocyte growth factor and its receptor.

Authors:  F Galimi; M F Brizzi; P M Comoglio
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

7.  Identification and dynamics of a heparin-binding site in hepatocyte growth factor.

Authors:  H Zhou; J R Casas-Finet; R Heath Coats; J D Kaufman; S J Stahl; P T Wingfield; J S Rubin; D P Bottaro; R A Byrd
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

8.  HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor.

Authors:  K Date; K Matsumoto; H Shimura; M Tanaka; T Nakamura
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

Review 9.  Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.

Authors:  C Birchmeier; E Gherardi
Journal:  Trends Cell Biol       Date:  1998-10       Impact factor: 20.808

10.  Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.

Authors:  M Ultsch; N A Lokker; P J Godowski; A M de Vos
Journal:  Structure       Date:  1998-11-15       Impact factor: 5.006

View more
  7 in total

1.  Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Authors:  Wendy M Mars; Minji Jo; Steven L Gonias
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

2.  Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Authors:  Gang Zeng; Udayan Apte; Amanda Micsenyi; Aaron Bell; Satdarshan P S Monga
Journal:  Exp Cell Res       Date:  2006-08-10       Impact factor: 3.905

3.  In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.

Authors:  Daniel F Gaddy; Michael J Riedel; Sharmila Pejawar-Gaddy; Timothy J Kieffer; Paul D Robbins
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

Review 4.  Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair.

Authors:  Rachel N Frisch; Kevin M Curtis; Kristina K Aenlle; Guy A Howard
Journal:  Expert Opin Ther Targets       Date:  2016-03-21       Impact factor: 6.902

Review 5.  MET: a critical player in tumorigenesis and therapeutic target.

Authors:  Carrie R Graveel; David Tolbert; George F Vande Woude
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

6.  Antigenicity of recombinant maltose binding protein-Mycobacterium avium subsp. paratuberculosis fusion proteins with and without factor Xa cleaving.

Authors:  Ratna B Gurung; Douglas J Begg; Auriol C Purdie; John P Bannantine; Richard J Whittington
Journal:  Clin Vaccine Immunol       Date:  2013-10-16

7.  A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.

Authors:  W David Tolbert; Jennifer Daugherty; ChongFeng Gao; Qian Xie; Cindy Miranti; Ermanno Gherardi; George Vande Woude; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.